DrugPatentWatch Database Preview
Dialysis Sups Company Profile
» See Plans and Pricing
What is the competitive landscape for DIALYSIS SUPS, and what generic alternatives to DIALYSIS SUPS drugs are available?
DIALYSIS SUPS has one approved drug.
There is one US patent protecting DIALYSIS SUPS drugs.
There are four patent family members on DIALYSIS SUPS drugs in four countries and fifteen supplementary protection certificates in seven countries.
Summary for Dialysis Sups
| International Patents: | 4 |
| US Patents: | 1 |
| Tradenames: | 2 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Dialysis Sups
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dialysis Sups | NORMOCARB HF 35 | magnesium chloride; sodium bicarbonate; sodium chloride | SOLUTION;INJECTION | 021910-002 | Jul 26, 2006 | RX | Yes | Yes | Get Started for $10 | Get Started for $10 | |||||
| Dialysis Sups | NORMOCARB HF 25 | magnesium chloride; sodium bicarbonate; sodium chloride | SOLUTION;INJECTION | 021910-001 | Jul 26, 2006 | RX | Yes | Yes | 7,300,674 | Get Started for $10 | Y | Get Started for $10 | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Dialysis Sups
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Dialysis Sups | NORMOCARB HF 25 | magnesium chloride; sodium bicarbonate; sodium chloride | SOLUTION;INJECTION | 021910-001 | Jul 26, 2006 | 5,945,449 | Get Started for $10 |
| Dialysis Sups | NORMOCARB HF 35 | magnesium chloride; sodium bicarbonate; sodium chloride | SOLUTION;INJECTION | 021910-002 | Jul 26, 2006 | 5,945,449 | Get Started for $10 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Dialysis Sups Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2365787 | Get Started for $10 |
| European Patent Office | 1347795 | Get Started for $10 |
| Australia | 2620902 | Get Started for $10 |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Dialysis Sups Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1499331 | C300615 | Netherlands | Get Started for $10 | PRODUCT NAME: NATRIUMSULFAAT, MAGNESIUMSULFAAT EN KALIUMSULFAAT; NAT. REGISTRATION NO/DATE: RVG 110863 20130417; FIRST REGISTRATION: BE 434323 20130220 |
| 1020461 | 300482 | Netherlands | Get Started for $10 | PRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMZOUT; NATIONAL REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: GB PL 17091/0263 - 0001 20101105 |
| 0984957 | 122012000051 | Germany | Get Started for $10 | PRODUCT NAME: KOMBINATIONSPRODUKT UMFASSEND NAPROXEN UND ESOMEPRAZOL-MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 85145.00.00 20120202; FIRST REGISTRATION: GROSSBRITANNIEN PL 17901/0263 - 0001 20101105 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
